Conditions: Asthma
Keywords: Asthma Symbicort Turbuhaler
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 25
Healthy volunteers: no

Brief summary:
The primary objective of the study is to compare the tolerability of Symbicort® Turbuhaler® 160/4.5 μg 10 inhalations with terbutaline Turbuhaler® 0.4 mg 10 inhalations for 3 days on top of Symbicort® Turbuhaler® 160/4.5 μg 1 inhalation twice a day (bid) in adult asthma patients.

Detailed description:

Arms:
arm 1: Symbicort Turbuhaler 160/4.5μg for 3 days First , then Terbutaline Turbuhaler 0.4 mg for 3 days arm 2: Terbutaline Turbuhaler 0.4 mg for 3 days First, then Symbicort Turbuhaler 160/4.5μg for 3 days,

Interventions: intervention 1: Symbicort Turbuhaler intervention 2: Terbutaline Turbuhaler
Intervention descriptions: intervention 1: 160/4.5μg for 3 days intervention 2: 0.4 mg for 3 days

Protocol document: